XOMA Royalty (XOMA) Capital Expenditures (QoQ) (2010 - 2016)
XOMA Royalty (XOMA) Capital Expenditures (QoQ) (2010 - 2016) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2016 |
186.11% |
| Dec 31, 2015 |
-160.00% |
| Sep 30, 2015 |
-66.85% |
| Jun 30, 2015 |
-19.56% |
| Mar 31, 2015 |
129.59% |
| Dec 31, 2014 |
-33.33% |
| Sep 30, 2014 |
374.19% |
| Jun 30, 2014 |
-36.73% |
| Mar 31, 2014 |
-51.00% |
| Dec 31, 2013 |
-52.38% |
| Sep 30, 2013 |
-41.83% |
| Jun 30, 2013 |
-27.51% |
| Mar 31, 2013 |
20.87% |
| Dec 31, 2012 |
-57.79% |
| Sep 30, 2012 |
70.33% |
| Jun 30, 2012 |
4.56% |
| Mar 31, 2012 |
-23.68% |
| Dec 31, 2011 |
115.62% |
| Sep 30, 2011 |
-75.60% |
| Jun 30, 2011 |
53.72% |
